The endoscopic system helps diagnose and treat multiple uterine and urological conditions. Credit: Roman Zaiets / Shutterstock.com.

Luminelle has signed a marketing agreement with the US Women’s Health Alliance (USWHA) for its endoscopic system.

As part of the deal, the LUMINELLE SUSTAINE endoscopic system will be supplied to OBGYN medical practices and their patients across more than 1,100 Alliance healthcare practices.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The agreement also enables Luminelle to access more than 5,000 providers in 34 US states.

USWHA president Jack Feltz said: “We champion physicians and patients by bringing the best and latest technology to the office setting. We believe that devices like LUMINELLE are essential to delivering simple and cost-effective diagnosis and treatment options for women.”

The endoscopic system has been developed to easily diagnose and treat multiple uterine and urological conditions.

See Also:

It uses interchangeable accessories and high‐tech optics to meet the growing requirements of physicians.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The endoscopic system, which serves as an alternative to costly hospital procedures, already received approval from the US Food and Drug Administration (FDA).

Luminelle CEO Allison London Brown said: “We have a shared mission in providing better clinical outcomes and cost-effective solutions to gynaecological practices and their patients, which is increasingly important, especially in these economically challenging times.

“We are committed to delivering the USWHA members a lower-cost alternative for physicians to treat patients in their office, and to provide practices the best option for care.”

Luminelle is engaged in the development of cost-effective, point-of-care diagnostic and operative solutions.